Advertisement

Topics

Swedish Company Enters US Trials with a New Drug for Osteoarthritis

05:55 EDT 17 Aug 2017 | Labiotech.eu

The FDA has accepted Medivir’s application to start clinical development of MIV-711, a drug with the potential to improve current care of osteoarthritis patients. Medivir is a pharmaceutical company based in Stockholm best known for a partnership with J&J’s Janssen ...

This awesome article Swedish Company Enters US Trials with a New Drug for Osteoarthritis appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: Swedish Company Enters US Trials with a New Drug for Osteoarthritis

NEXT ARTICLE

More From BioPortfolio on "Swedish Company Enters US Trials with a New Drug for Osteoarthritis"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Arthritis
Arthritis is by definition the inflammation of one or more joints, characterized by swelling, pain, warmth, redness and diminished range of joint movement (Oxford Medical Dictionary). There are many different types; Noninflammatory; Osteoarthritis, N...